It is a myth that cancer is prevalent only in urban areas More than 5,56,000 cancer deaths occurred in India in 2010 and 71.1 per cent of those who died were aged between 30 and 69 years, says a report on cancer mortality in India, published in the March 28 issue of The Lancet. While men in the age group of 30-69 years are more likely to die of oral cancers followed...
More »SEARCH RESULT
More Benefit than Cost-Alaka M Basu
For women, the NREGA would bring important social gains Not being an expert on the subject and too lazy to read all the fine print, I do not know the exact allocations under the Mahatma Gandhi National Rural Employment Guarantee Act this year. But I gather the money has been cut down, largely because the sums allocated last year were not fully used by most states. Maybe there were other considerations...
More »Cheap generics no panacea for India's poorest
-Reuters Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital. "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...
More »Fasting Ganga activist referred to AIIMS
-PTI Noted environmentalist GD Agrawal, who is on "fast-unto-death" to press for cleaning up of river Ganga, was on Monday referred from BHU to AIIMS in New Delhi after his health deteriorated further. Also known as Swami Gyanswaroop Anand, Agrawal was recently transferred to the Sir Sundal Lal Hospital of Benaras Hindu University (BHU) from the district hospital after suffering a heart attack. He was taken to New Delhi on an air...
More »GEAC, experts slip on basics? by Latha Jishnu
As the biotech industry takes heart from the prime minister’s remark, a fresh report shows India’s regulation and expertise on GM crops are sloppy BUOYED by the prime minister’s remark that NGOs were responsible for the moratorium on the release of GM or Bt brinjal, the biotech industry is stepping up its campaign to get it lifted along with “all constraints in the research and development work of biotech crops”. It...
More »